Clinical Trial Update: Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome [NA]

View source ↗

Summary

This clinical trial update reports on a completed investigation into how the probiotic combination VSL#3 may act in irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• VSL#3

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED